Centers | ||
Weccome Centre for Anti-Infectives Research | Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | FDA Oncology Center of Excellence Project Catalyst | 
WCAIR brings together the Drug Discovery Unit (DDU) , the Mode of Action group and the Parasitology research groups. With the daily interactions of these groups, parasitology and drug discovery can work together in synergy. This empowers us to  create... Read more | 
				Chulalongkorn
 Drug Discovery and Drug Development Research Center (Chula4DR) was 
established in 2017, with the aim to facilitate advancement of academic 
drug discovery and drug development research by leveraging innovations 
and  sciences... Read more | 
				Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation  | 
					
Partnerships | 
						Events | 
						Jobs | 
					
							
							
							Research Collaboration and license agreementBeactica Therapeutics AB, the Swedish drug discovery company, and University of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration agreement. The two parties will work together in a project... View all Evotec and Yale University to collaborate on cancer therapyEvotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this collaboration is to identify novel mechanisms, targets and... View all Merck Establishes New Center in San Diego with Academic ResearchersMerck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will be led by Peter Schulz from the Scripps Research... View all  | 
						
						 No EVENTS for listing  | 
						
								
 No Job Posts  | 
					


